Clinical Trial Update: Hand, Foot, and Mouth Disease: Could EPs®7630 be a Treatment Option [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for EPs®7630 in Hand, Foot, and Mouth Disease undergoing Phase 2 and Phase 3 evaluation; status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand Foot and Mouth Disease

Drugs mentioned

• EPs 7630 (Pelargonium sidoides root extract)

Snippet

Sponsor: Eskisehir Osmangazi University | Conditions: Hand, Foot, and Mouth Disease | Phase 2, Phase 3 | Status: COMPLETED